Search Results for Therapeutics

1.

Macromolecular Anticancer Therapeutics

Author

Reddy, L. Harivardhan. editor. Couvreur, Patrick. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1007/978-1-4419-0507-9

Format:

Availability

Online Library~1

Available:
Copies:

2.

Targeted Therapeutics in Melanoma

Author

Gajewski, Thomas F. editor. Hodi, F. Stephen. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1007/978-1-61779-407-0

Format:

Availability

Online Library~1

Available:
Copies:

3.

Pharmaceutical Perspectives of Cancer Therapeutics

Author

Lu, Yi. editor. Mahato, Ram I. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1007/978-1-4419-0131-6

Format:

Availability

Online Library~1

Available:
Copies:

4.

Stem Cell Research and Therapeutics

Author

Shi, Yanhong. editor. Clegg, Dennis O. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1007/978-1-4020-8502-4

Format:

Availability

Online Library~1

Available:
Copies:

5.

Bone Metastasis Experimental and Clinical Therapeutics

Author

Singh, Gurmit. editor. Rabbani, Shafaat A. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1385/1592598927

Format:

Availability

Online Library~1

Available:
Copies:

6.

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

Author

Yarden, Yosef. editor. Elkabets, Moshe. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

https://doi.org/10.1007/978-3-319-67932-7

Format:

Availability

Online Library~1

Available:
Copies:

7.

Cover image for Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics

Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics

Author

Manisekaran, Ravichandran. author. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

https://doi.org/10.1007/978-3-319-67609-8

Format:

Availability

Online Library~1

Available:
Copies:

8.

Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

Author

Tao, Jianguo. editor. Sotomayor, Eduardo. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1007/978-94-007-5028-9

Format:

Availability

Online Library~1

Available:
Copies:

9.

Insulin-like Growth Factors and Cancer From Basic Biology to Therapeutics

Author

LeRoith, Derek. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1007/978-1-4614-0598-6

Format:

Availability

Online Library~1

Available:
Copies:

10.

Prostate Cancer Biology, Genetics, and the New Therapeutics

Author

Chung, Leland W. K. editor. Isaacs, William B. editor. Simons, Jonathan W. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

http://dx.doi.org/10.1007/978-1-59745-224-3

Format:

Availability

Online Library~1

Available:
Copies:

11.

Resistance to Ibritumomab in Lymphoma

Author

Hosono, Makoto. editor. Chatal, Jean-François. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

https://doi.org/10.1007/978-3-319-78238-6

Format:

Availability

Online Library~1

Available:
Copies:

12.

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas

Author

Ferreri, Andrés J. M. editor. SpringerLink (Online service)

Preferred Shelf Number

ONLINE

Electronic Access

https://doi.org/10.1007/978-3-319-75184-9

Format:

Availability

Online Library~1

Available:
Copies:

	{displayName}	{count}
{error}